Prelude Capital Management’s NRC Health Common Stock NRC Stock Holding History

Prelude Capital Management’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-400	Closed	-$23K	–	2148
2019 Q3	$23K	Buy	+400	New	+$24.8K	﹤0.01%	1364
2017 Q3	–	Sell	-200	Closed	-$5K	–	1821
2017 Q2	$5K	Sell	200 -205	-51%	-$5.01K	﹤0.01%	1468
2017 Q1	$8K	Buy	+405	New	+$7.49K	﹤0.01%	1380
2016 Q3	–	Sell	-2,745	Closed	-$38K	–	1742
2016 Q2	$38K	Buy	2,745 +2,343	+583%	+$33K	0.01%	1100
2016 Q1	$6K	Buy	+402	New	+$5.89K	﹤0.01%	1191
2015 Q4	–	Sell	-555	Closed	-$7K	–	1615
2015 Q3	$7K	Sell	555 -1,432	-72%	-$19K	﹤0.01%	1372
2015 Q2	$28K	Sell	1,987 -500	-20%	-$7.08K	﹤0.01%	1291
2015 Q1	$36K	Sell	2,487 -2,413	-49%	-$34.1K	0.01%	1561
2014 Q4	$69K	Buy	4,900 +2,200	+81%	+$32.3K	0.01%	1148
2014 Q3	$35K	Sell	2,700 -4,400	-62%	-$60.5K	﹤0.01%	1550
2014 Q2	$99K	Buy	+7,100	New	+$107K	0.01%	1103

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prelude Capital Management's NRC Position: Q4 2019 in Review

Prelude Capital Management sold out of NRC Health Common Stock (NRC) in Q4 2019, closing a stake of 400 shares — an estimated $23K sold.

Prelude Capital Management first reported a position in NRC in Q2 2014 and held it in 11 quarters. The position peaked at $99K in Q2 2014. 103 funds tracked by Wall St. Rank hold NRC as of Q4 2019.

Prelude Capital Management reported no remaining NRC Health Common Stock position as of Q4 2019 after selling out during the quarter.
Prelude Capital Management sold 400 NRC Health Common Stock shares in Q4 2019, an estimated $23K.
Prelude Capital Management first reported a position in NRC Health Common Stock in Q2 2014 and held it in 11 quarters.
Prelude Capital Management's NRC Health Common Stock position peaked at $99K in Q2 2014.
103 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.